Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy

AIMS: As evidenced by scintigraphy imaging, the prevalence of transthyretin (TTR) cardiac amyloidosis in heart failure patients with preserved ejection fraction (HFpEF) and left ventricular hypertrophy (LVH) ranges between 13% and 19%. The natural evolution of cardiac amyloidosis begins with the dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Devesa, Ana, Camblor Blasco, Andrea, Pello Lázaro, Ana María, Askari, Elham, Lapeña, Gregoria, Gómez Talavera, Sandra, Taibo Urquía, Mikel, Rodríguez Olleros, Celia, Tuñón, José, Ibáñez, Borja, Aceña, Álvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318443/
https://www.ncbi.nlm.nih.gov/pubmed/33963812
http://dx.doi.org/10.1002/ehf2.13360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318443/
https://www.ncbi.nlm.nih.gov/pubmed/33963812
http://dx.doi.org/10.1002/ehf2.13360

Ejemplares similares